The multi-partner team will integrate new technologies across the entire mAb production workflow, from cell line development to purification
The Phase 2 study tested two dose levels of pumitamig alongside four standard chemotherapy regimens across first
This strategic investment aims to bolster the company's position as a global leader in Vitamin D3 manufacturing
The partnership also allows both companies to explore CR-001 and SKB105 as monotherapies and in combination
The collaboration will establish the MUMPMP–Agilent BioDiscovery Hub
Captured microbes are then neutralized on engineered microbicidal surfaces
The company introduced the ExcelSign E12 and E17 modular patient monitors, the Relife 1000 biphasic defibrillator, and a new OT charting software
Angelini Ventures has already invested €125 million in 22 startups
Subscribe To Our Newsletter & Stay Updated